Live Chat

Problematic Pioglitazone

Pioglitazone, an active ingredient in Actos medications such as Actoplus Met, Actoplus Met XR, and Duetact, is more dangerous than many patients realize. In fact, on the basis of a nearly 200,000 person study, the FDA concluded that long-term pioglitazone patients have a substantially increased likelihood of developing life-threatening health conditions. While the most serious of these conditions is bladder cancer, it’s important to note that other pioglitazone-linked conditions include heart failure and bone fractures.

 

Is pioglitazone an active ingredient in one of your medications? If so, you should contact the legal professionals at Fears Nachawati. With years of experience and dedicated expertise, we know how to fight for patients like you. Don’t settle for second best. Talk to our attorneys today. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. We’re ready to fight for you!

Categories
Drug Litigation

Problematic Pioglitazone